INS and type 2 diabetes mellitus: A recent RCT (NCT01541215) was able to confirm that 1.8 mg of liraglutide per day (added to metformin, with or without basal insulin) improves glycaemic control in children and adolescents with T2DM, with only an increased frequency of adverse gastrointestinal events, mainly nausea [81].